• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    7/22/22 2:51:24 PM ET
    $APDN
    $ATRA
    $AUGX
    $AVAH
    Other Consumer Services
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $APDN alert in real time by email

     

    During Friday's session, 61 companies made new 52-week lows.

    Areas of Interest About Today's 52-Week Lows:

    • Verizon Communications (NYSE:VZ) was the biggest company in terms of market cap to set a new 52-week low.
    • Kiora Pharmaceuticals (NASDAQ:KPRX) is the smallest company on a market cap basis to set a new 52-week low.
    • VistaGen Therapeutics (NASDAQ:VTGN) saw the most significant move of the companies, as shares traded down 85.49% to reach its new 52-week low.
    • Shapeways Hldgs (NYSE:SHPW) shares rebounded the highest, with shares trading up 0.16%, bouncing back after reaching its new 52-week low.

    During thn Friday, the following stocks set new 52-week lows:

    • Verizon Communications (NYSE:VZ) shares set a new 52-week low of $44.38. The stock traded down 6.41%.
    • Snap (NYSE:SNAP) stock achieved a new 52-week low on Friday morning, hitting $10.07 and moving down 37.57%.
    • Turkcell Iletisim (NYSE:TKC) stock set a new 52-week low of $2.43 on Friday, moving down 1.62%.
    • Integral Ad Science (NASDAQ:IAS) shares reached a new 52-week low of $9.03 on Friday morning, moving down 9.6%.
    • Gorilla Technology Gr (NASDAQ:GRRR) shares set a new yearly low of $11.66 this morning. The stock was down 6.77% on the session.
    • Ivanhoe Electric (AMEX:IE) stock drifted down 1.41% on Friday morning to hit a new 52-week low of $7.35.
    • Azul (NYSE:AZUL) shares set a new yearly low of $6.32 this morning. The stock was down 3.27% on the session.
    • Mondee Hldgs (NASDAQ:MOND) stock drifted down 6.36% on Friday morning to hit a new 52-week low of $7.30.
    • Nuvation Bio (NYSE:NUVB) shares hit a yearly low of $3.06. The stock was down 3.56% on the session.
    • Insteel Indus (NYSE:IIIN) stock hit $32.06 on Friday morning, setting a new 52-week low for a change of down 4.54%.
    • Eagle Pharmaceuticals (NASDAQ:EGRX) shares made a new 52-week low of $39.94 on Friday. The stock was down 1.02% for the day.
    • Cardlytics (NASDAQ:CDLX) stock hit $13.04 on Friday morning, setting a new 52-week low for a change of down 3.9%.
    • Banco BBVA Argentina (NYSE:BBAR) stock achieved a new 52-week low on Friday morning, hitting $2.03 and moving down 1.41%.
    • Cazoo Gr (NYSE:CZOO) shares set a new 52-week low of $0.50. The stock traded down 5.23%.
    • Aveanna Healthcare Hldgs (NASDAQ:AVAH) shares hit a yearly low of $2.02. The stock was down 7.17% on the session.
    • BigBear.ai Hldgs (NYSE:BBAI) stock achieved a new 52-week low on Friday morning, hitting $2.77 and moving down 17.75%.
    • Atara Biotherapeutics (NASDAQ:ATRA) stock drifted down 7.68% on Friday morning to hit a new 52-week low of $3.26.
    • SelectQuote (NYSE:SLQT) stock broke to a new 52-week low of $1.76 on Friday. Shares of the company traded down 4.23%.
    • Glatfelter (NYSE:GLT) stock dropped to a yearly low on Friday of $6.11. Shares traded down 0.47%.
    • Colony Bankcorp (NASDAQ:CBAN) shares hit a yearly low of $13.88. The stock was down 6.16% on the session.
    • Doma Holdings (NYSE:DOMA) shares reached a new 52-week low of $0.74 on Friday morning, moving down 4.12%.
    • Duddell Street Acq (NASDAQ:DSAC) shares set a new 52-week low of $9.44. The stock traded down 5.69%.
    • Virax Biolabs Group (NASDAQ:VRAX) shares set a new 52-week low of $15.32. The stock traded down 11.79%.
    • Embark Technology (NASDAQ:EMBK) stock drifted down 8.21% on Friday morning to hit a new 52-week low of $0.38.
    • Penns Woods Bancorp (NASDAQ:PWOD) stock broke to a new 52-week low of $21.60 on Friday. Shares of the company traded down 2.46%.
    • Yiren Digital (NYSE:YRD) stock hit a new 52-week low of $1.53. The stock was down 2.05% on the session.
    • Standard BioTools (NASDAQ:LAB) stock hit $1.43 on Friday morning, setting a new 52-week low for a change of up 1.54%.
    • Knightscope (NASDAQ:KSCP) stock dropped to a yearly low on Friday of $2.80. Shares traded down 3.37%.
    • High Tide (NASDAQ:HITI) shares made a new 52-week low of $1.56 on Friday. The stock was down 0.63% for the day.
    • Gamida Cell (NASDAQ:GMDA) shares moved down 5.0% on Friday to hit a new 52-week low of $1.60, drifting down 5.0%.
    • Brookline Capital (NASDAQ:BCAC) stock achieved a new 52-week low on Friday morning, hitting $9.50 and moving down 3.43%.
    • Augmedix (NASDAQ:AUGX) stock drifted down 1.23% on Friday morning to hit a new 52-week low of $1.48.
    • United Insurance Holdings (NASDAQ:UIHC) stock hit $1.21 on Friday morning, setting a new 52-week low for a change of down 2.41%.
    • Cryo-Cell International (NASDAQ:CCEL) shares reached a new 52-week low of $5.60 on Friday morning, moving down 7.9%.
    • Shapeways Hldgs (NYSE:SHPW) shares hit a yearly low of $0.91. The stock was down 0.16% on the session.
    • VistaGen Therapeutics (NASDAQ:VTGN) shares reached a new 52-week low of $0.15 on Friday morning, moving down 85.49%.
    • Humanigen (NASDAQ:HGEN) stock set a new 52-week low of $0.44 on Friday, moving down 4.07%.
    • Educational Development (NASDAQ:EDUC) stock set a new 52-week low of $3.50 on Friday, moving down 2.04%.
    • Integrated Media Tech (NASDAQ:IMTE) stock hit a new 52-week low of $1.77. The stock was down 9.13% on the session.
    • Vascular Biogenics (NASDAQ:VBLT) stock achieved a new 52-week low on Friday morning, hitting $0.32 and moving down 12.9%.
    • Code Chain New Continent (NASDAQ:CCNC) shares moved down 12.35% on Friday to hit a new 52-week low of $0.38, drifting down 12.35%.
    • Qualigen Therapeutics (NASDAQ:QLGN) shares set a new yearly low of $0.43 this morning. The stock was down 2.55% on the session.
    • Qumu (NASDAQ:QUMU) shares were down 3.27% for the day, having made a 52-week low of $0.64.
    • Ra Medical Systems (AMEX:RMED) stock achieved a new 52-week low on Friday morning, hitting $0.19 and moving down 40.74%.
    • Altamira Therapeutics (NASDAQ:CYTO) stock set a new 52-week low of $0.42 on Friday, moving down 4.59%.
    • Applied DNA Sciences (NASDAQ:APDN) stock broke to a new 52-week low of $0.62 on Friday. Shares of the company traded up 10.13%.
    • Kiora Pharmaceuticals (NASDAQ:KPRX) stock broke to a new 52-week low of $0.14 on Friday. Shares of the company traded down 42.08%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $APDN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APDN
    $ATRA
    $AUGX
    $AVAH

    CompanyDatePrice TargetRatingAnalyst
    Snap Inc.
    $SNAP
    2/6/2026$5.50Sell → Hold
    Stifel
    Snap Inc.
    $SNAP
    2/5/2026$10.00Neutral → Buy
    BofA Securities
    Colony Bankcorp Inc.
    $CBAN
    2/2/2026$21.00 → $22.00Outperform
    Hovde Group
    Verizon Communications Inc.
    $VZ
    1/22/2026$43.00Equal Weight
    Barclays
    Snap Inc.
    $SNAP
    1/14/2026$8.00Underperform
    BNP Paribas Exane
    Atara Biotherapeutics Inc.
    $ATRA
    1/13/2026$6.00Buy → Hold
    Canaccord Genuity
    BigBear.ai Inc.
    $BBAI
    1/7/2026$6.00Overweight → Neutral
    Cantor Fitzgerald
    Vistagen Therapeutics Inc.
    $VTGN
    12/17/2025$0.90Buy → Hold
    Jefferies
    More analyst ratings

    $APDN
    $ATRA
    $AUGX
    $AVAH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

    For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

    11/9/23 2:30:20 PM ET
    $SRAX
    $SNAP
    Advertising
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $APDN
    $ATRA
    $AUGX
    $AVAH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Daedalus Special Acquisition Llc bought 435,000 units of Class A Ordinary Shares (SEC Form 4)

    4 - Daedalus Special Acquisition Corp. (0002082149) (Issuer)

    12/10/25 5:23:06 PM ET
    $DSAC
    Blank Checks
    Finance

    Co-Chief Executive Officer Kilic Orkun bought 435,000 units of Class A Ordinary Shares (SEC Form 4)

    4 - Daedalus Special Acquisition Corp. (0002082149) (Issuer)

    12/10/25 5:21:57 PM ET
    $DSAC
    Blank Checks
    Finance

    Co-Chief Executive Officer Babayigit Husnu Akin bought 435,000 units of Class A Ordinary Shares (SEC Form 4)

    4 - Daedalus Special Acquisition Corp. (0002082149) (Issuer)

    12/10/25 5:20:58 PM ET
    $DSAC
    Blank Checks
    Finance

    $APDN
    $ATRA
    $AUGX
    $AVAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by EVP and Group CEO-VZ Business Malady Kyle

    4 - VERIZON COMMUNICATIONS INC (0000732712) (Issuer)

    2/6/26 12:31:52 PM ET
    $VZ
    Telecommunications Equipment
    Public Utilities

    SEC Form 4 filed by EVP and Chief Legal Officer Venkatesh Vandana

    4 - VERIZON COMMUNICATIONS INC (0000732712) (Issuer)

    2/6/26 12:30:24 PM ET
    $VZ
    Telecommunications Equipment
    Public Utilities

    SEC Form 4 filed by EVP & Chief HR Officer Hammock Samantha

    4 - VERIZON COMMUNICATIONS INC (0000732712) (Issuer)

    2/6/26 12:31:15 PM ET
    $VZ
    Telecommunications Equipment
    Public Utilities

    $APDN
    $ATRA
    $AUGX
    $AVAH
    SEC Filings

    View All

    Vistagen Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Vistagen Therapeutics, Inc. (0001411685) (Filer)

    2/6/26 4:12:22 PM ET
    $VTGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 8-K filed by Verizon Communications Inc.

    8-K - VERIZON COMMUNICATIONS INC (0000732712) (Filer)

    2/5/26 4:15:50 PM ET
    $VZ
    Telecommunications Equipment
    Public Utilities

    SEC Form 10-Q filed by SelectQuote Inc.

    10-Q - SelectQuote, Inc. (0001794783) (Filer)

    2/5/26 9:01:30 AM ET
    $SLQT
    Specialty Insurers
    Finance

    $APDN
    $ATRA
    $AUGX
    $AVAH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Snap Inc. Files Annual Report on Form 10-K

    Snap Inc. (NYSE:SNAP) has filed its Annual Report on Form 10-K for the year ended December 31, 2025, with the Securities and Exchange Commission. The report, which includes Snap Inc.'s audited financial statements, is accessible at investor.snap.com. A printed copy of the report may be requested free of charge by any stockholder by requesting a copy in writing to: Corporate Secretary, Snap Inc., 3000 31st Street, Santa Monica, California, 90405 USA. The report is also available at www.sec.gov. About Snap Inc. Snap Inc. is a technology company. We believe the camera presents the greatest opportunity to improve the way people live and communicate. We contribute to human progress by empo

    2/5/26 9:10:00 AM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    Knightscope Retains Lake Street to Support Growth Through Acquisitions

    Knightscope, Inc. (NASDAQ:KSCP), a security technology company building the Nation's first Autonomous Security Force, today announced that it has retained Lake Street Capital Markets, a full-service investment bank, as its exclusive buy-side financial advisor to support the Company's growth strategy through acquisitions of complementary businesses, technologies, and capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205409078/en/ This engagement reflects Knightscope's ongoing efforts to strengthen its market position and accelerate growth through selective, disciplined acquisitions aligned with its long-term strateg

    2/5/26 9:00:00 AM ET
    $KSCP
    Telecommunications Equipment
    Telecommunications

    SelectQuote, Inc. Reports Second Quarter of Fiscal Year 2026 Results

    Second Quarter of Fiscal Year 2026 – Consolidated Earnings Highlights Revenue of $537.1 million Net income of $69.3 million Adjusted EBITDA* of $84.7 million Fiscal Year 2026 Guidance Ranges: Revenue expected in a range of $1.61 billion to $1.71 billion Adjusted EBITDA* expected in a range of $90 million to $100 million Second Quarter Fiscal Year 2026 – Segment Highlights Senior Revenue of $261.5 million Adjusted EBITDA of $102.5 million Approved Medicare Advantage policies of 257,279 Healthcare Services Revenue of $230.7 million Adjusted EBITDA of $0.8 million 113,483 SelectRx members Life Revenue of $43.6 million Adjusted EBITDA of $5.6

    2/5/26 7:00:00 AM ET
    $SLQT
    Specialty Insurers
    Finance

    $APDN
    $ATRA
    $AUGX
    $AVAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Snap upgraded by Stifel with a new price target

    Stifel upgraded Snap from Sell to Hold and set a new price target of $5.50

    2/6/26 8:05:59 AM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    Snap upgraded by BofA Securities with a new price target

    BofA Securities upgraded Snap from Neutral to Buy and set a new price target of $10.00

    2/5/26 6:52:31 AM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    Hovde Group reiterated coverage on Colony Bankcorp with a new price target

    Hovde Group reiterated coverage of Colony Bankcorp with a rating of Outperform and set a new price target of $22.00 from $21.00 previously

    2/2/26 6:45:19 AM ET
    $CBAN
    Major Banks
    Finance

    $APDN
    $ATRA
    $AUGX
    $AVAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/10/24 4:15:32 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    $APDN
    $ATRA
    $AUGX
    $AVAH
    Financials

    Live finance-specific insights

    View All

    SelectQuote, Inc. Reports Second Quarter of Fiscal Year 2026 Results

    Second Quarter of Fiscal Year 2026 – Consolidated Earnings Highlights Revenue of $537.1 million Net income of $69.3 million Adjusted EBITDA* of $84.7 million Fiscal Year 2026 Guidance Ranges: Revenue expected in a range of $1.61 billion to $1.71 billion Adjusted EBITDA* expected in a range of $90 million to $100 million Second Quarter Fiscal Year 2026 – Segment Highlights Senior Revenue of $261.5 million Adjusted EBITDA of $102.5 million Approved Medicare Advantage policies of 257,279 Healthcare Services Revenue of $230.7 million Adjusted EBITDA of $0.8 million 113,483 SelectRx members Life Revenue of $43.6 million Adjusted EBITDA of $5.6

    2/5/26 7:00:00 AM ET
    $SLQT
    Specialty Insurers
    Finance

    Snap Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

    Fourth quarter revenue increased 10% year-over-year to $1,716 million Fourth quarter gross margin of 59%, up 4 percentage points sequentially and 2 percentage points year-over-year Fourth quarter operating cash flow was $270 million and Free Cash Flow was $206 million Fourth quarter net income of $45 million and Adjusted EBITDA of $358 million Snap Inc. (NYSE:SNAP) today announced financial results for the quarter and full year ended December 31, 2025. "Our Q4 results began to reflect the impact of our strategic pivot toward profitable growth, translating into revenue diversification and meaningful margin expansion," said Evan Spiegel, CEO. "This progress reflects our commitment t

    2/4/26 4:10:00 PM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    Vistagen to Report Fiscal Year 2026 Third Quarter Results and Host Corporate Update Conference Call on February 12, 2026

    Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will host a conference call and webcast on Thursday, February 12, 2026, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to report results for its fiscal year 2026 third quarter ended December 31, 2025, and provide a corporate update. The conference call is being webcast live, and a link can be found under "Events" in the Investors section of the Company's website. Please click on the webcast link and follow the prompts for registration and access at

    2/4/26 8:30:00 AM ET
    $VTGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APDN
    $ATRA
    $AUGX
    $AVAH
    Leadership Updates

    Live Leadership Updates

    View All

    StandardAero Set to Join S&P MidCap 400

    NEW YORK, Jan. 16, 2026 /PRNewswire/ -- StandardAero Inc. (NYSE:SARO) will replace Frontier Communications Parent Inc. (NASD: FYBR) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, January 22. S&P 500 & S&P 100 constituent Verizon Communications Inc. (NYSE:VZ) is acquiring Frontier Communications Parent in a deal expected to close soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Jan 22, 2026 S&P MidCap 400 Addition StandardAero SARO Industrials Jan 22, 2026 S&P MidCap 400 Deletion Frontier Communicati

    1/16/26 6:26:00 PM ET
    $FYBR
    $SARO
    $SPGI
    Telecommunications Equipment
    Telecommunications
    Aerospace
    Industrials

    IAS APPOINTS MELISSA FURZE AS HEAD OF DATA SCIENCE

    Former LinkedIn executive to scale IAS's data science and AI capabilities worldwide NEW YORK, Dec. 22, 2025 /PRNewswire/ -- Integral Ad Science (NASDAQ:IAS), a leading global media measurement and optimization platform, today announced that Melissa Furze joined the company as Head of Data Science at IAS reporting to the Chief Technology Officer. Melissa will lead the company's global data science, AI, and analytics strategy, partnering closely with product, engineering, and the commercial teams to accelerate innovation, strengthen protection and performance capabilities, and deliver trusted, data-driven outcomes for advertisers and publishers worldwide.

    12/22/25 8:00:00 AM ET
    $IAS
    Computer Software: Programming Data Processing
    Technology

    Cardlytics Appoints Company Alumnus David Evans as Chief Financial Officer

    Cardlytics Inc. (NASDAQ:CDLX) today announced the appointment of David Evans as its new Chief Financial Officer, effective January 12, 2026. Evans is returning to Cardlytics, having previously held several executive roles including Chief Financial Officer and Chief Administrative Officer. As the returning Chief Financial Officer, Evans will oversee Cardlytics' finance, accounting, and investor relations functions as the company continues to execute against its longer-term growth vision. Evans rejoins Cardlytics after his initial tenure from 2014 to 2020, during which he helped guide the company through its earlier years of growth and a successful IPO in 2018. Evans is a seasoned executive

    12/18/25 8:10:00 AM ET
    $CDLX
    Computer Software: Programming Data Processing
    Technology